1.Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
Mark D GONZALEZ ; Allison R MCMULLEN ; Meghan A WALLACE ; Matthew P CROTTY ; David J RITCHIE ; Carey Ann D BURNHAM
Annals of Laboratory Medicine 2017;37(2):174-176
No abstract available.
Anti-Bacterial Agents/*pharmacology
;
Azabicyclo Compounds/*pharmacology
;
Bacterial Proteins/genetics
;
Ceftazidime/*pharmacology
;
Cephalosporins/*pharmacology
;
DNA, Bacterial/genetics/metabolism
;
Drug Resistance, Bacterial/*drug effects
;
Gram-Negative Bacteria/drug effects/*isolation & purification
;
Humans
;
Microbial Sensitivity Tests
;
Penicillanic Acid/*analogs & derivatives/pharmacology
;
Pseudomonas aeruginosa/drug effects/isolation & purification
;
Real-Time Polymerase Chain Reaction
3.Thyroxine (T4) Autoantibody Interference of Free T4 Concentration Measurement in a Patient With Hashimoto's Thyroiditis.
Mi Na LEE ; Soo Youn LEE ; Kyu Yeon HUR ; Hyung Doo PARK
Annals of Laboratory Medicine 2017;37(2):169-171
No abstract available.
Adult
;
Autoantibodies/*immunology
;
Female
;
Hashimoto Disease/*diagnosis
;
Humans
;
Luminescent Measurements
;
Radioimmunoassay
;
Republic of Korea
;
Thyroid Function Tests
;
Thyroxine/*blood/immunology
;
Triiodothyronine/blood
4.A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma.
Dahae YANG ; Sung Ran CHO ; Seri JUNG ; Woonhyoung LEE ; Hyun Yong HWANG ; Ho Seop LEE ; Yang Soo KIM ; Jong Rak CHOI ; Mi Hyang KIM
Annals of Laboratory Medicine 2017;37(2):166-168
No abstract available.
Aged
;
Antineoplastic Combined Chemotherapy Protocols/adverse effects
;
Bone Marrow Cells/cytology/pathology
;
Female
;
Flow Cytometry
;
Fusion Proteins, bcr-abl/*genetics
;
Granulocyte Colony-Stimulating Factor/therapeutic use
;
Humans
;
Immunophenotyping
;
Leukemia/*diagnosis/etiology
;
Lymphoma, Large B-Cell, Diffuse/*drug therapy
;
Phenotype
;
Rituximab/administration & dosage
5.Familial Hemophagocytic Lymphohistiocytosis Type 2 in a Korean Infant With Compound Heterozygous PRF1 Defects Involving a PRF1 Mutation, c.1091T>G.
Min Sun KIM ; Young Uk CHO ; Seongsoo JANG ; Eul Ju SEO ; Ho Joon IM ; Chan Jeoung PARK
Annals of Laboratory Medicine 2017;37(2):162-165
No abstract available.
Asian Continental Ancestry Group/*genetics
;
Base Sequence
;
Bone Marrow Cells/cytology/pathology
;
Cytomegalovirus Infections/diagnosis
;
Epstein-Barr Virus Infections/diagnosis
;
Female
;
Flow Cytometry
;
Heterozygote
;
Humans
;
Infant
;
Killer Cells, Natural/cytology/immunology
;
Lymphohistiocytosis, Hemophagocytic/*diagnosis/genetics
;
Perforin/*genetics
;
Phagocytosis
;
Polymorphism, Single Nucleotide
;
Republic of Korea
;
Sequence Analysis, DNA
6.Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations.
Yoko KUBUKI ; Kotaro SHIDE ; Takuro KAMEDA ; Takumi YAMAJI ; Masaaki SEKINE ; Ayako KAMIUNTEN ; Keiichi AKIZUKI ; Haruko SHIMODA ; Yuki TAHIRA ; Kenichi NAKAMURA ; Hiroo ABE ; Tadashi MIIKE ; Hisayoshi IWAKIRI ; Yoshihiro TAHARA ; Mitsue SUETA ; Kanna HASHIMOTO ; Shojiro YAMAMOTO ; Satoru HASUIKE ; Tomonori HIDAKA ; Kenji NAGATA ; Akira KITANAKA ; Kazuya SHIMODA
Annals of Laboratory Medicine 2017;37(2):159-161
No abstract available.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Amino Acid Sequence
;
Calreticulin/*genetics
;
Child
;
DNA/chemistry/genetics/metabolism
;
Exons
;
Female
;
Humans
;
Janus Kinase 2/*genetics
;
Male
;
Middle Aged
;
Molecular Sequence Data
;
Polymorphism, Single Nucleotide
;
Receptors, Thrombopoietin/genetics
;
Sequence Analysis, DNA
;
Sex Factors
;
Thrombocythemia, Essential/*diagnosis/genetics
;
Young Adult
7.Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis.
Keren COHEN-HAGAI ; Gloria RASHID ; Yael EINBINDER ; Meital OHANA ; Sydney BENCHETRIT ; Tali ZITMAN-GAL
Annals of Laboratory Medicine 2017;37(2):155-158
Von Willebrand factor (vWF) is a glycoprotein with a crucial role in the formation of platelet thrombi, and ADAMTS13 is the main enzyme responsible for vWF cleavage. Both are important in the relationship between diabetic nephropathy, hypercoagulability, and cardiovascular disease. This study evaluated a potential relationship between vitamin D (vitD) levels, vWF, ADAMTS13 activity, and inflammation in diabetic patients on chronic hemodialysis (HD). Blood samples from 52 diabetic patients on chronic HD were obtained to determine vitD levels, vWF, and ADAMTS13 activity, and inflammatory markers. HD patients were grouped according to 25-hydroxyvitamin D [25(OH) VitD]<25 nmol/L (n=16) or >25 nmol/L (n=36). vWF antigen and vWF activity were elevated in both groups, with an average of 214.3±82.6% and 175.8±72.6%, respectively. Average ADAMTS13 activity was within the normal range in both groups. Blood samples from the vitD <25 nmol/L group showed a positive correlation between c-reactive protein (CRP) and vWF levels (P=0.023; r=0.564; 95% confidence interval=0.095-0.828), with a negative correlation between HbA1c and 25(OH) VitD (P=0.015; r=-0.337; 95% confidence interval=-0.337-0.19). Diabetic patients on chronic HD had elevated vWF levels and activity with no significant change in ADAMTS13 activity. The correlation between CRP and vWF levels in the 25(OH) VitD<25 nmol/L group suggests inflammatory-related endothelial dysfunction in these patients.
ADAMTS13 Protein/*metabolism
;
Aged
;
C-Reactive Protein/analysis
;
Diabetes Mellitus, Type 2/complications/*diagnosis/metabolism
;
Female
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
Male
;
Middle Aged
;
Renal Dialysis
;
Renal Insufficiency, Chronic/complications/*diagnosis/metabolism
;
Vitamin D/*analogs & derivatives/blood
;
von Willebrand Factor/*metabolism
8.Dengue Virus Serotypes Circulating in Khyber Pakhtunkhwa Province, Pakistan, 2013-2015.
Muhammad SULEMAN ; Rani FARYAL ; Muhammad Masroor ALAM ; Salmaan SHARIF ; Shahzad SHAUKAT ; Uzma Bashir AAMIR ; Adnan KHURSHID ; Mehar ANGEZ ; Massab UMAIR ; Mian Muhammad SUFIAN ; Yasir ARSHAD ; Syed Sohail Zahoor ZAIDI
Annals of Laboratory Medicine 2017;37(2):151-154
From 2013 to 2015, the National Institute of Health, Pakistan, received 1,270 blood samples of suspected dengue cases reported from inpatient and outpatient departments of various hospitals in Khyber Pakhtunkhwa (KPK) province. In this study, we determined the circulating dengue virus (DENV) serotypes using real-time reverse transcriptase (RT)-PCR to understand the serotype-based epidemiology of DENV. All four serotypes (DENV-1 [6%], DENV-2 [33%], DENV-3 [47%], and DENV-4 [0.1%]) were found circulating during the study period. Our findings suggest the need for an active surveillance system coupled with the laboratory diagnosis, especially in the chronic endemic areas of the country. Public awareness programs are needed for effective control and prevention of outbreaks in the future.
Adolescent
;
Adult
;
Dengue/diagnosis/*epidemiology/virology
;
Dengue Virus/genetics/*isolation & purification
;
Disease Outbreaks
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pakistan/epidemiology
;
RNA, Viral/genetics/metabolism
;
Real-Time Polymerase Chain Reaction
;
Serogroup
;
Young Adult
9.Performance of the Real-Q EBV Quantification Kit for Epstein-Barr Virus DNA Quantification in Whole Blood.
Hee Jae HUH ; Jong Eun PARK ; Ji Youn KIM ; Sun Ae YUN ; Myoung Keun LEE ; Nam Yong LEE ; Jong Won KIM ; Chang Seok KI
Annals of Laboratory Medicine 2017;37(2):147-150
There has been increasing interest in standardized and quantitative Epstein-Barr virus (EBV) DNA testing for the management of EBV disease. We evaluated the performance of the Real-Q EBV Quantification Kit (BioSewoom, Korea) in whole blood (WB). Nucleic acid extraction and real-time PCR were performed by using the MagNA Pure 96 (Roche Diagnostics, Germany) and 7500 Fast real-time PCR system (Applied Biosystems, USA), respectively. Assay sensitivity, linearity, and conversion factor were determined by using the World Health Organization international standard diluted in EBV-negative WB. We used 81 WB clinical specimens to compare performance of the Real-Q EBV Quantification Kit and artus EBV RG PCR Kit (Qiagen, Germany). The limit of detection (LOD) and limit of quantification (LOQ) for the Real-Q kit were 453 and 750 IU/mL, respectively. The conversion factor from EBV genomic copies to IU was 0.62. The linear range of the assay was from 750 to 10⁶ IU/mL. Viral load values measured with the Real-Q assay were on average 0.54 log₁₀ copies/mL higher than those measured with the artus assay. The Real-Q assay offered good analytical performance for EBV DNA quantification in WB.
DNA, Viral/*blood/metabolism
;
Epstein-Barr Virus Infections/diagnosis/virology
;
Herpesvirus 4, Human/*genetics/isolation & purification
;
Humans
;
Limit of Detection
;
Reagent Kits, Diagnostic
;
Real-Time Polymerase Chain Reaction
10.Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain.
Rossella MARINO ; Laura MAGRINI ; Francesca ORSINI ; Veronica RUSSO ; Patrizia CARDELLI ; Gerardo SALERNO ; Mina HUR ; Salvatore DI SOMMA
Annals of Laboratory Medicine 2017;37(2):137-146
BACKGROUND: High-sensitivity cardiac troponin I (hs-cTnI) and the soluble isoform of suppression of tumorigenicity 2 (sST2) are useful prognostic biomarkers in acute coronary syndrome (ACS). The aim of this study was to test the short term prognostic value of sST2 compared with hs-cTnI in patients with chest pain. METHODS: Assays for hs-cTnI and sST2 were performed in 157 patients admitted to the Emergency Department (ED) for chest pain at arrival. In-hospital and 30-day follow-up mortalities were assessed. RESULTS: The incidence of ACS was 37%; 33 patients were diagnosed with ST elevation myocardial infarction (STEMI), and 25 were diagnosed with non-ST elevation myocardial infarction (NSTEMI). Compared with the no acute coronary syndrome (NO ACS) group, the median level of hs-cTnI was higher in ACS patients: 7.22 (5.24-14) pg/mL vs 68 (15.33-163.50) pg/mL (P<0.0001). In all patients, the sST2 level at arrival showed higher independent predictive power than hs-cTnI (odds ratio [OR] 20.13, P<0.0001 and OR 2.61, P<0.0008, respectively). sST2 at ED arrival showed a greater prognostic value for cardiovascular events in STEMI (area under the curve [AUC] 0.80, P<0.001) than NSTEMI patients (AUC 0.72, P<0.05). Overall, 51% of the STEMI patients with an sST2 value>35 ng/mL at ED arrival died during the 30-day follow-up. CONCLUSIONS: sST2 has a greater prognostic value for 30-day cardiac mortality after discharge in patients presenting to the ED for chest pain compared with hs-cTnI. In STEMI patients, an sST2 value >35 ng/mL at ED arrival showed the highest predictive power for short-term mortality.
Acute Coronary Syndrome/diagnosis/*mortality
;
Aged
;
Area Under Curve
;
Biomarkers/analysis
;
Chest Pain
;
Emergency Service, Hospital
;
Female
;
Follow-Up Studies
;
Humans
;
Interleukin-1 Receptor-Like 1 Protein/*analysis
;
Male
;
Middle Aged
;
Odds Ratio
;
Prognosis
;
ROC Curve
;
Troponin I/*analysis